ĀÜĄņĀŅĀ×

Dr. Palejwala has 18 years of experience in drug discovery and development. Since 2012, Dr. Palejwala served as Director of Discovery and Preclinical Research at Synergy Pharmaceuticals Inc. where he actively contributed to establishing preclinical animal models for testing therapeutic efficacy and mechanism of action of plecanatide (Trulanceā„¢) and dolcanatide in the gastrointestinal tract. He also prepared the preclinical pharmacology section of NDA for Trulanceā„¢.

From 2001 - 2012, Dr. Palejwala served as Discovery Scientist/Manager at Sanofi Pharmaceuticals contributing to advancing small molecule and biologic programs in immunology, inflammation, oncology, CNS, and metabolic disorders. He contributed to establishing and managing high throughput gene expression profiling platform capabilities at Sanofi and collaborated/contributed in cross-cultural/cross-functional team settings.

Dr. Palejwala received his Ph.D. degree in Microbiology from the M. S. University of Baroda in India and post-doctoral training in Molecular Genetics at the University of Medicine and Dentistry in New Jersey.